Verma Meghnath, Bhargav Hemant, Varambally Shivarama, Raghuram Nagarathna, Bn Gangadhar
School of Yoga and Life Sciences, S-VYASA Yoga University, No.19, EknathBhavan, Gavipuram circle, Kempegowda Nagar, Bangalore560019, Karnataka, India.
NIMHANS, Integrate Centre for Yoga, Department of Psychiatry, National Institute of Mental Health and Neuro Sciences (NIMHANS), Hosur Road, Lakkasandra, Bengaluru560029, India.
J Complement Integr Med. 2018 Jun 26;16(1):jcim-2017-0155. doi: 10.1515/jcim-2017-0155.
Background Twenty one (12 females) subjects, diagnosed with schizophrenia by a psychiatrist using ICD-10, in the ages 52.87 + 9.5 years and suffering since 24.0 ± 3.05 years were recruited into the study from a schizophrenia rehabilitation center in Bengaluru. Methods All subjects were taking anti-psychotic medications and were in stable state for more than a month. Psychiatric medications were kept constant during the study period. Assessments were done at three points of time: (1) baseline, (2) after one month of usual routine (pre) and (3) after five months of validated Integrated Yoga (IY) intervention (post). Validated 1 h Yoga module (consisting of asanas, pranayama, relaxation techniques and chantings) was practiced for 5 months, five sessions per week. Antipsychotic-induced side effects were assessed using Simpson Angus Scale (SAS) and Udvalg for Kliniske Undersogelser (UKU) side effect rating scale. Cognitive functions (using Trail making Test A and B), clinical symptoms and anthropometry were assessed as secondary variables. Comparisons between "pre" and "post" data was done using paired samples t-tests after subtracting baseline scores from them respectively. Results At the end of five months, significant reduction in drug-induced Parkinsonian symptoms (SAS score; p=0.001) and 38 items of UKU scale was observed along with significant improvement in processing speed, executive functions and negative symptoms of schizophrenia patients. No side effects of Yoga were reported. Conclusions The present study provides preliminary evidence for usefulness of Integrated Yoga intervention in managing anti-psychotic-induced side effects.
从班加罗尔的一家精神分裂症康复中心招募了21名(12名女性)受试者,这些受试者由精神科医生根据国际疾病分类第10版(ICD - 10)诊断为精神分裂症,年龄为52.87±9.5岁,患病时间为24.0±3.05年。方法:所有受试者均在服用抗精神病药物,且病情稳定超过一个月。在研究期间,精神科药物保持不变。在三个时间点进行评估:(1)基线,(2)常规日常活动一个月后(前),以及(3)经过5个月的经验证的综合瑜伽(IY)干预后(后)。经验证的1小时瑜伽模块(包括体式、呼吸控制法、放松技巧和唱诵)每周进行5次,共练习5个月。使用辛普森·安格斯量表(SAS)和临床研究综合量表(UKU)副作用评定量表评估抗精神病药物引起的副作用。将认知功能(使用连线测验A和B)、临床症状和人体测量作为次要变量进行评估。分别从“前”和“后”数据中减去基线分数后,使用配对样本t检验进行比较。结果:在5个月末,观察到药物引起的帕金森症状(SAS评分;p = 0.001)和UKU量表的38项显著降低,同时精神分裂症患者的处理速度、执行功能和阴性症状有显著改善。未报告瑜伽的副作用。结论:本研究为综合瑜伽干预在管理抗精神病药物引起的副作用方面的有效性提供了初步证据。